Amyloid-β remains an important therapeutic target in Alzheimer’s disease (AD), experts say While amyloid has been shown to play a key role in the pathogenesis of AD, clinical trials of therapies targeting amyloid have been largely disappointing to date. This has led experts to consider the need for treatment earlier within the disease process before ...
The amyloid puzzle: current concepts and controversies in Alzheimer’s disease
23 Aug 2021
Sponsored by Biogen Australia Pty Ltd